North America Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

March 2022 | 132 pages | ID: ND6932514548EN
GMD Research

Abstracts

North America pharmaceutical contract research organization (CRO) market is projected to grow by 9.0% annually in the forecast period and reach $37.61 billion by 2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.

Highlighted with 59 tables and 44 figures, this 132-page report “North America Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire North America pharmaceutical contract research organization (CRO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2030 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America pharmaceutical contract research organization (CRO) market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country.

Based on Service, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.

• CRO for Pre-clinical Development
• CRO for Phase I Trials
• CRO for Phase II Trials
• CRO for Phase III Trials
• CRO for Phase IV Trials
• Laboratory Services
• Consulting Services
• Data Management Services

Based on Therapeutic Application, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.

• Infectious Diseases
• Oncology
• Metabolic Disorders
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Gastrointestinal Disorders
• Other Therapeutic Applications

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.

• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes

Geographically, the following national/local markets are fully investigated:

• U.S.
• Canada
• Mexico

For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2021-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

• Charles River Laboratories
• CMIC Co. Ltd
• Covance Inc.
• Hangzhou Tigermed Consulting Co., Ltd.
• ICON Plc
• IQVIA Holdings Inc.
• LSK Global Pharma Service Co., Ltd.
• Novotech Pty Ltd
• PAREXEL International Corporation
• Pharmaceutical Product Development LLC (PPD)
• PRA Health Sciences Inc.
• Quanticate Ltd
• Samsung Bioepis Co., Ltd.
• SGS SA (SGS Life Sciences)
• Syneos Health Inc.
• WuXi AppTec Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF NORTH AMERICA MARKET BY SERVICE

3.1 Market Overview by Service
3.2 CRO for Pre-clinical Development
3.3 CRO for Phase I Trials
3.4 CRO for Phase II Trials
3.5 CRO for Phase III Trials
3.6 CRO for Phase IV Trials
3.7 Laboratory Services
3.8 Consulting Services
3.9 Data Management Services

4 SEGMENTATION OF NORTH AMERICA MARKET BY THERAPEUTIC APPLICATION

4.1 Market Overview by Therapeutic Application
4.2 Infectious Diseases
4.3 Oncology
4.4 Metabolic Disorders
4.5 Cardiovascular Disorders
4.6 Central Nervous System
4.7 Respiratory Disorders
4.8 Gastrointestinal Disorders
4.9 Other Therapeutic Applications

5 SEGMENTATION OF NORTH AMERICA MARKET BY END USER

5.1 Market Overview by End User
5.2 Pharmaceutical & Biopharmaceutical Companies
5.3 Medical Device Companies
5.4 Academic Institutes

6 NORTH AMERICA MARKET 2019-2030 BY COUNTRY

6.1 Overview of North America Market
6.2 U.S.
6.3 Canada
6.4 Mexico

7 COMPETITIVE LANDSCAPE

7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co., Ltd.
ICON Plc
IQVIA Holdings Inc.
LSK North America Pharma Service Co., Ltd.
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co., Ltd.
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.

8 INVESTING IN NORTH AMERICA MARKET: RISK ASSESSMENT AND MANAGEMENT

8.1 Risk Evaluation of North America Market
8.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of North America Pharmaceutical CRO Market in Balanced Perspective, 2019-2030
Table 2. World Economic Outlook, 2021-2031
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 4. Worldwide Total Number of Registered Clinical Trials
Table 5. World Health Spending by Region, $ bn, 2013-2020
Table 6. Main Product Trends and Market Opportunities in North America Pharmaceutical CRO Market
Table 7. North America Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 8. North America Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 9. North America Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 10. North America Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 11. U.S. Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 12. U.S. Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 13. U.S. Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 14. Canada Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 15. Canada Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 16. Canada Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 17. Mexico Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 18. Mexico Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 19. Mexico Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 20. Breakdown of World Market by Key Vendor, 2020, %
Table 21. Charles River Laboratories: Company Snapshot
Table 22. Charles River Laboratories: Product Portfolio
Table 23. CMIC Co. Ltd.: Company Snapshot
Table 24. CMIC Co. Ltd.: Business Segmentation
Table 25. CMIC Co. Ltd.: Revenue by Region, 2018, %
Table 26. Covance Inc.: Company Snapshot
Table 27. Covance Inc.: Product Portfolio
Table 28. Covance Inc.: Revenue by Region, 2020, %
Table 29. Hangzhou Tigermed Consulting Co., Ltd.: Company Snapshot
Table 30. Hangzhou Tigermed Consulting Co., Ltd.: Business Segmentation
Table 31. ICON Plc: Company Snapshot
Table 32. ICON Plc: Business Segmentation
Table 33. ICON Plc: Product Portfolio
Table 34. ICON Plc: Revenue by Region, 2020, %
Table 35. IQVIA Holdings Inc.: Company Snapshot
Table 36. IQVIA Holdings Inc.: Business Segmentation
Table 37. IQVIA Holdings Inc.: Revenue by Region, 2020, %
Table 38. IQVIA Holdings Inc.: Product Portfolio
Table 39. LSK North America Pharma Service Co., Ltd.: Company Snapshot
Table 40. Novotech Pty Ltd: Company Snapshot
Table 41. PAREXEL International Corporation: Company Snapshot
Table 42. PAREXEL International Corporation: Business Segmentation
Table 43. PAREXEL International Corporation: Revenue by Region, 2018, %
Table 44. PAREXEL International Corporation: Product Portfolio
Table 45. Pharmaceutical Product Development LLC (PPD): Company Snapshot
Table 46. PRA Health Sciences Inc.: Company Snapshot
Table 47. PRA Health Sciences Inc.: Business Segmentation
Table 48. PRA Health Sciences Inc.: Revenue by Region, 2018, %
Table 49. Quanticate Ltd: Company Snapshot
Table 50. Samsung Bioepis Co., Ltd.: Company Snapshot
Table 51. SGS SA (SGS Life Sciences): Company Snapshot
Table 52. SGS SA (SGS Life Sciences): Business Segmentation
Table 53. SGS SA (SGS Life Sciences): Revenue by Region, 2018, %
Table 54. Syneos Health Inc.: Company Snapshot
Table 55. Syneos Health Inc.: Business Segmentation
Table 56. Syneos Health Inc.: Revenue by Region, 2018, %
Table 57. WuXi AppTec Inc.: Company Snapshot
Table 58. Risk Evaluation for Investing in North America Market, 2021-2030
Table 59. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2030
Figure 5. North America Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of North America Pharmaceutical CRO Market
Figure 8. Leading Causes of Death in the World, 2019-2020, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of North America Pharmaceutical CRO Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of North America Pharmaceutical CRO Market
Figure 14. Breakdown of North America Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue
Figure 15. North America Addressable Market Cap in 2022-2030 by Service, Value ($ bn) and Share (%)
Figure 16. North America Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn
Figure 17. North America Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn
Figure 18. North America Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn
Figure 19. North America Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn
Figure 20. North America Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn
Figure 21. North America Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn
Figure 22. North America Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn
Figure 23. North America Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn
Figure 24. Breakdown of North America Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue
Figure 25. North America Addressable Market Cap in 2022-2030 by Therapeutic Application, Value ($ bn) and Share (%)
Figure 26. North America Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn
Figure 27. North America Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn
Figure 28. North America Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn
Figure 29. North America Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn
Figure 30. North America Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn
Figure 31. North America Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn
Figure 32. North America Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn
Figure 33. North America Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn
Figure 34. Breakdown of North America Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue
Figure 35. North America Addressable Market Cap in 2022-2030 by End User, Value ($ bn) and Share (%)
Figure 36. North America Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn
Figure 37. North America Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn
Figure 38. North America Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn
Figure 39. Breakdown of North America Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue
Figure 40. Contribution to North America 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 41. U.S. Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 42. Canada Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 43. Pharmaceutical CRO Market in Mexico, 2015-2030, $ bn
Figure 44. Growth Stage of North America Pharmaceutical CRO Industry over the Forecast Period